Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Beta ...
SueWallSt reminds purchasers of Beta Bionics, Inc. (NASDAQ: BBNX) securities that a securities class action has been filed on ...
Zacks Investment Research on MSN
Beta Bionics stock down despite iLet-Eversense 365 integration deal
Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated insulin delivery (AID) platform and Senseonics’ continuous glucose ...
Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system with Abbott's upcoming ...
Beta Bionics, Inc. BBNX shares rallied 15.3% in the last trading session to close at $22.18. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.
SAN DIEGO, Sept. 7, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise ...
Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results